The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Browse all articles A–Z →
Onfi Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for neurologists and prescribers on the Onfi (clobazam) shortage in 2026: supply landscape, clinical risks, therapeutic alternatives, and patient support tools.

Opill 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
Opill is widely available OTC but patients still encounter access barriers. Here's what clinicians need to know about Opill availability, coverage gaps, and counseling patients in 2026.

Os-Cal 500 With D Availability: What Providers and Prescribers Need to Know in 2026
Os-Cal 500 With D isn't in a national shortage, but patients still struggle to find it. Here's what prescribers need to know about availability, alternatives, and patient guidance in 2026.

Outgro Pain Relief Shortage: What Providers and Prescribers Need to Know in 2026
Outgro Pain Relief has largely disappeared from retail. Providers should know the clinical context, FDA history, and how to guide patients toward appropriate OTC alternatives.
48,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.

Oxtellar XR Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview for neurologists, epileptologists, and PCPs on Oxtellar XR availability challenges in 2026, including patient access strategies and alternative options.

Palforzia Shortage: What Providers and Prescribers Need to Know in 2026
Palforzia commercialization ends July 31, 2026. This provider guide covers the discontinuation timeline, transition planning for current patients, and alternative OIT strategies.

Pandel Shortage: What Providers and Prescribers Need to Know in 2026
Pandel availability challenges affect patient care in 2026. Here is what prescribers and providers need to know about Pandel's brand-only status and how to support patients.

Paragard Shortage: What Providers and Prescribers Need to Know in 2026
Paragard access challenges in 2026 are real, even without a formal FDA shortage. Here's what prescribers need to know about availability, litigation, and patient counseling.

Paromomycin Shortage: What Providers and Prescribers Need to Know in 2026
The paromomycin generic was discontinued in 2021. Here's a clinical guide for providers on supply status, alternatives, prior auth, and patient assistance in 2026.

Paxil Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of paroxetine availability in 2026 for providers: which formulations are at risk, how to manage patient supply issues, and when to consider alternatives.

Pentasa XR Shortage: What Providers and Prescribers Need to Know in 2026
The 2026 mesalamine ER shortage is affecting patients across the country. Here's what gastroenterologists and PCPs need to know about clinical alternatives, prior auth, and patient communication.

Perforomist Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on Perforomist availability issues in 2026 — including stocking challenges, therapeutic alternatives, and patient management strategies.